Latest Biotech News

Roivant’s Priovant Therapeutics received FDA clearance for Lisraya (brepocitinib) to treat adults with dermatomyositis, marking another label win in a fast-moving rare-inflammation pipeline. The...

DualityBio and Genentech (Roche) entered a collaboration and license agreement to develop next-generation antibody-drug conjugates built around DualityBio’s DUPAC payload platform. The deal...

The FDA granted fast track designation to CytomX’s varsetatug masetecan (Varseta-M; CX-2051), an EpCAM-directed masked, conditionally activated antibody-drug conjugate, for relapsed or refractory...

AusperBio raised $120 million in a Series C round to advance its oligonucleotide therapy for chronic hepatitis B through Phase 3 and beyond. The company’s strategy focuses on moving an oligo...

Two separate studies outlined new protein-level mechanisms for chronic hepatitis B control, both linking innate antiviral effectors to HBV biology. One report described IFI35 degrading HNF4α to...

A Delaware jury found that Parse Biosciences, a subsidiary of Qiagen, willfully infringed three patents belonging to Scale Biosciences—acquired by 10x Genomics in 2025—while also upholding those...

Researchers at Boston University’s Center for Regenerative Medicine and Boston Medical Center reported a scalable iPSC-based method to generate CD4+ helper T cells for CAR T manufacturing. The...

A retrospective and observational clinical study from Children’s Hospital Colorado and other centers was not included; instead, the included cardiology device update points to kidney-protective...

A new funding dataset reports biopharma money raised through late August 2026, providing a read on capital availability across public, private, and other financing channels. The figure tracks...

The FDA has approved Eli Lilly’s Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes who are at high risk for events. The approval is based on results from the...

Roivant’s Priovant Therapeutics won FDA approval for Lisraya (brepocitinib) to treat adult dermatomyositis, a rare systemic autoimmune disease. The clearance marks Priovant’s first approved...

BioNTech and Genentech terminated a Phase 2 program for their personalized mRNA cancer vaccine after outcomes failed to match control benchmarks and the trial was described as recording more...

Moderna raised $2.6 billion to support its cancer strategy after securing a “big win” in a key study, according to the report. The financing reflects investor demand to fund late-stage and...

Genentech is partnering with DualityBio on next-generation antibody-drug conjugates, with $45 million paid upfront and potential milestone payments exceeding $1 billion. The collaboration uses...

BioXcel Therapeutics filed for Chapter 11 bankruptcy after evaluating strategic options and failing to secure sufficient funding. Teva has emerged as stalking-horse bidder, proposing to acquire...

Researchers at Boston University and Boston Medical Center reported a scalable stem-cell approach to generate functional CD4+ helper T cells for next-generation CAR T designs. In a Stem Cell...

The FDA granted Fast Track designation to CytomX Therapeutics’ varsetatug masetecan (Varseta-M; CX-2051) for relapsed/refractory metastatic colorectal cancer. The ADC targets EpCAM and uses a...

Adicet Bio said the FDA cleared its IND for ADI-212, setting up early clinical evaluation in patients with metastatic castration-resistant prostate cancer (mCRPC). The clearance provides...

CRISPR Therapeutics presented updated early data on its lipid-lowering gene editing therapy at the European Society of Cardiology meeting, showing mixed durability about a year after dosing. The...

The FDA expanded the cardiometabolic reach of GLP-1/GIP therapy by approving Eli Lilly’s tirzepatide (Mounjaro) to reduce cardiovascular risk in adults with type 2 diabetes, based on SURPASS-CVOT....